logo
Trekking Far And Wide To Eradicate Polio In Pakistan

Trekking Far And Wide To Eradicate Polio In Pakistan

Forbes4 hours ago

A look at the dedicated health workers crossing Pakistan to reach 45 million children in one week with the lifesaving polio vaccine, with support from UNICEF and Rotary International.
A husband and wife health worker team ride camelback to deliver the polio vaccine to children on their route in Pakistan. The couple is part of a massive national campaign to vaccinate 45 million children under 5 against wild poliovirus.
Four decades ago, wild poliovirus paralyzed hundreds of children every day, with an estimated 350,000 cases in more than 125 countries. Today, polio is on the brink of eradication with just two endemic countries left: Afghanistan and Pakistan.
The path to this remarkable public health milestone began in 1988 when UNICEF, Rotary International and other partners formed the Global Polio Eradication Initiative (GPEI) to spearhead a massive vaccination campaign that has decreased cases globally by over 99 percent.
GPEI, along with national government and community health partners, vaccinates 400 million children against polio every year. These campaigns prevent an estimated 650,000 cases of paralysis and save up to 60,000 children's lives each year.
This immersive video follows teams of vaccinators in Pakistan as they traverse the country, by any conveyance necessary — on foot, by motorbike and even camelback — to reach children living in the country's most remote areas. In less than one week, 45 million children under 5 will be visited, identified and vaccinated against polio.
Watch the video to see polio vaccinators in action
UNICEF and Rotary International are working together to create a polio-free world for children
Until polio transmission is eliminated in every country, all countries remain at risk. To fully eradicate polio, no child can be missed and there is no time to lose.
Ending polio will be a historic public health milestone, making polio the second infectious disease, after smallpox, to be certified eradicated. Because of the experience, support and partnership of UNICEF and countless Rotary members across the decades powering and driving forward millions of dedicated vaccinators, we are almost there.
Learn more about UNICEF and Rotary International's longstanding partnership.
UNICEF does not endorse any brand, company, organization, product or service.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Novo Nordisk Ends Partnership with Hims & Hers
Novo Nordisk Ends Partnership with Hims & Hers

Wall Street Journal

time27 minutes ago

  • Wall Street Journal

Novo Nordisk Ends Partnership with Hims & Hers

Novo Nordisk has ended its collaboration with Hims & Hers Health for its Wegovy weight-loss blockbuster treatment roughly a month after it began over concerns about what it said was illegal mass compounding and deceptive marketing by the telehealth company. The healthcare company said on Monday that it would no longer be working with San Francisco-based Hims & Hers, and that direct access to Wegovy would no longer be available to Hims & Hers via its NovoCare Pharmacy arm.

Canaccord Genuity Keeps Buy Rating on Clover Health (CLOV)
Canaccord Genuity Keeps Buy Rating on Clover Health (CLOV)

Yahoo

timean hour ago

  • Yahoo

Canaccord Genuity Keeps Buy Rating on Clover Health (CLOV)

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the 11 Best US Stocks to Invest in Under $5. On April 8, Canaccord Genuity analyst Richard Close reiterated a 'Buy' rating on Clover Health Investments, Corp. (NASDAQ:CLOV) with a price target of $4.50. According to the analyst, the final rate update is good news for Clover Health Investments, Corp. (NASDAQ:CLOV). Close believes this change will help the company and could also improve the managed care sector's overall sentiment. An older Medicare-eligible consumer smiling happily while receiving healthcare services at a clinic. The company is expected to continue growing strongly in 2025. This growth will also help Clover Health Investments, Corp. (NASDAQ:CLOV) in 2026 as the company benefits from reimbursements tied to having a 4-Star rating. Canaccord Genuity will be looking at the competitive landscape closely as new plans for 2026 are introduced. Close noted that the positive rate update should improve the outlook for the managed care sector. Clover Health Investments, Corp. (NASDAQ:CLOV) is an American company that provides Medicare Advantage insurance plans. While we acknowledge the potential of CLOV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store